XTX Topco’s Inhibrx INBX Stock Holding History

XTX Topco’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	18,363 -1,763	-9%	-$177K	0.02%	1253
2026 Q1	$1.35M	Buy	20,126 +11,105	+123%	+$824K	0.02%	1171
2025 Q4	$713K	Buy	+9,021	New	+$615K	0.02%	1298
2025 Q2	–	Sell	-16,918	Closed	-$237K	–	2740
2025 Q1	$237K	Buy	+16,918	New	+$230K	0.01%	1585

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's INBX Position: Q2 2026 in Review

XTX Topco reduced its Inhibrx (INBX) stake by 8.8% in Q2 2026, selling an estimated $177K and leaving 18,363 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #1253.

XTX Topco first reported a position in INBX in Q1 2025 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

XTX Topco held 18,363 shares of Inhibrx worth $1.74M as of Q2 2026.
XTX Topco sold 1,763 Inhibrx shares in Q2 2026, an estimated $177K.
Inhibrx made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1253 holding.
XTX Topco first reported a position in Inhibrx in Q1 2025 and has held it in 4 quarters since.
162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.